{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:52:54Z","timestamp":1792515174962,"version":"4.5.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Mucopolysaccharidosis (MPS) type I is a rare lysosomal storage disorder caused by an accumulation of glycosaminoglycans (GAGs) resulting in multisystem disease. Neurological morbidity includes hydrocephalus, spinal cord compression, and cognitive decline. While many neurological symptoms have been described, stroke is not a widely-recognized manifestation of MPS I. Accordingly, patients with MPS I are not routinely evaluated for stroke, and there are no guidelines for managing stroke in patients with this disease. We report the case of a child diagnosed with MPS I who presented with overt stroke and repeated neurological symptoms with imaging findings for severe ventriculomegaly, infarction, and bilateral terminal carotid artery stenosis. Direct intracranial pressure evaluation proved negative for hydrocephalus. The patient was subsequently treated with cerebral revascularization and at a 3-year follow-up, the patient reported no further neurological events or new ischemia on cerebral imaging. Cerebral arteriopathy in patients with MPS I may be associated with GAG accumulation within the cerebrovascular system and may predispose patients to recurrent strokes. However, further studies are required to elucidate the etiology of cerebrovascular arteriopathy in the setting of MPS I. Although the natural history of steno-occlusive arteriopathy in patients with MPS I remains unclear, our findings suggest that cerebral revascularization is a safe treatment option that may mitigate the risk of future strokes and should be strongly considered within the overall management guidelines for patients with MPS I.<\/jats:p>","DOI":"10.3389\/fped.2021.606905","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T04:52:06Z","timestamp":1623300726000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I"],"prefix":"10.3389","volume":"9","author":[{"given":"Nathan","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiani","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Burrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Luchtman-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Byars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Hammill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Wusick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Vadivelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1073\/pnas.69.8.2048","article-title":"The defect in the Hurler and Scheie syndromes: deficiency of \u03b1-L-Iduronidase","volume":"69","author":"Bach","year":"1972","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics."},{"key":"B3","first-page":"3421","article-title":"The mucopolysaccharidoses","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Neufeld","year":"2001"},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/01.GIM.0000154299.22120.6A","article-title":"Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome","volume":"7","author":"Grewal","year":"2005","journal-title":"Genet Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/sj.bmt.1705934","article-title":"Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome","volume":"41","author":"Tolar","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"B6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","article-title":"Enzyme replacement therapy prior to haematopoietic stem cell transplantation in mucopolysaccharidosis type I: 10 year combined experience of 2 centres","volume":"117","author":"Ghosh","year":"2016","journal-title":"Mol Genet Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis, and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J Inherit Metab Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00431-006-0316-8","article-title":"Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I","volume":"166","author":"Tokic","year":"2007","journal-title":"Eur J Pediatri."},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: efficacy and limitations","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital J Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2015.06.002","article-title":"Neurocognition across the spectrum of mucopolysaccharidosis type I: age severity, and treatment","volume":"116","author":"Shapiro","year":"2015","journal-title":"Mol Genet Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/gim.2016.223","article-title":"Cognitive outcomes and age of detection of severe mucopolysaccharidosis type I","volume":"19","author":"Grosse","year":"2017","journal-title":"Genet Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.09.006","article-title":"Scheie syndrome diagnosed after cerebral infarction","volume":"21","author":"Fujii","year":"2012","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.14744\/ejmo.2018.51523","article-title":"Acute stroke in a patient with mucopolysaccharidosis type I with increased carotid intima-media thickness","volume":"2","author":"Olgac","year":"2018","journal-title":"EJMO."},{"key":"B14","doi-asserted-by":"publisher","first-page":"17.17.1","DOI":"10.1002\/0471142905.hg1717s84","article-title":"Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I","volume":"84","author":"Johnson","year":"2015","journal-title":"Curr Protoc Hum Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00234-004-1215-1","article-title":"Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation","volume":"46","author":"Matheus","year":"2004","journal-title":"Neuroradiology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000120932","article-title":"Pial synangiosis for moyamoya syndrome in children","volume":"23","author":"Adelson","year":"1995","journal-title":"Pediatr Neurosurg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-2005-868160","article-title":"Surgical management of moyamoya syndrome","volume":"15","author":"Smith","year":"2005","journal-title":"Skull Base."},{"key":"B18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0022-3468(93)90240-L","article-title":"Children with mucopolysaccharidosis:perioperative care, morbidity, mortality, and new findings","volume":"28","author":"Belani","year":"1993","journal-title":"J Pediatr Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ccd.25183","article-title":"Percutaneous PFO closure for paradoxical stroke in 8-kg twins","volume":"84","author":"Hill","year":"2014","journal-title":"Catheter Cardiovasc Interv."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00381-017-3476-0","article-title":"Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?","volume":"33","author":"Dalla","year":"2017","journal-title":"Childs Nerv Syst."},{"key":"B22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1651-2227.2002.tb03330.x","article-title":"Cardiovascular changes in children with mucopolysaccharide disorders","volume":"91","author":"Mohan","year":"2002","journal-title":"Acta Paediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ymgme.2012.06.001","article-title":"Left ventricular aneurysm in an adult patient with mucopolysaccharidosis type I: comment on pathogenesis of a novel complication","volume":"106","author":"Cabrera","year":"2012","journal-title":"Mol Genet Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0002-9440(10)64961-9","article-title":"Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly","volume":"156","author":"Hinek","year":"2000","journal-title":"Am J Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/GIM.0b013e3181cdd687","article-title":"Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy","volume":"12","author":"Milewicz","year":"2010","journal-title":"Genet Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3171\/2010.10.PEDS10388","article-title":"Large vascular malformation in a child presenting with vascular steal phenomenon managed with pial synangiosis","volume":"7","author":"Ellis","year":"2011","journal-title":"J Neurosurg Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3171\/ped.2004.100.2.0142","article-title":"Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis","volume":"100","author":"Scott","year":"2004","journal-title":"J Neurosurg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3171\/2009.4.JNS081649","article-title":"Clinical outcome after 450 revascularization procedures for moyamoya disease","volume":"111","author":"Guzman","year":"2009","journal-title":"J Neurosurg."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.606905\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T04:52:10Z","timestamp":1623300730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.606905\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":29,"alternative-id":["10.3389\/fped.2021.606905"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.606905","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"article-number":"606905"}}